|
REVIEW PANEL ON NEW SARS CASE
AND BIOSAFETY
The 27-year-old patient is doing well and has
no fever. We expect
him to be discharged by Wednesday. He will be placed on a
14-day home
quarantine order. All contacts of the case remain well. He
is an
isolated case of low public health risk.
A 11-member panel chaired by Dr Antony
Della-Porta, an Australian
biosafety expert from the WHO, has been formed to review epidemiologic
data on the SARS case and the biosafety requirements and practices
at the
laboratories in relation to the recent SARS case in Singapore.
They will
also make recommendations on biosafety practices and standards.
The international experts on the panel started
work today and have
visited some of the laboratories in Singapore. They will be
having
further discussions with all the relevant parties.
The full composition of the panel:
CHAIRMAN
|
|
Dr Antony James Della-Porta
|
WHO Biosafety Expert |
| |
|
MEMBERS
|
|
A/P Chew Suok Kai
|
Deputy Director of Medical
Services
Epidemiology & Disease Control
Ministry of Health
|
Lee Chin Ek
|
Assistant Director
Ministry of Home Affairs
|
Dr Leo Yee Sin
|
Clinical Director
Communicable Disease Centre
|
Dr Ling Ai Ee
|
Head & Senior Consultant
Virology Lab
Dept of Pathology
Singapore General Hospital
|
Dr Ng Lee Ching
|
Defense Science Organisation |
Dr Sonja Olsen
|
US CDC Epidemiology Expert |
Dr Pierre E Rollin
|
US CDC Biosafety expert |
Dr Kazuyoshi Sugiyama
|
WHO Biosafety Expert |
Dr Tan Kok Keng
|
Chief Operating Officer
Temasek Life Sciences Laboratory
|
TERMS OF REFERENCE
1. Review epidemiologic data on the SARS
case.
2. Review biosafety requirements and practices
at the
laboratories in relation to the recent SARS case in Singapore,
in
the following areas:
a. Standard Microbiological Practices
b. Safety Equipment
c. Laboratory facilities
d. Training in biological safety
e. Other special practices
3. Recommend changes to address biosafety issues,
improve
practices and structural design of the laboratories.
4. Recommend the approaches to the adoption
of National Standards, Audit
and Accreditation for biological safety.
They are expected to complete their investigations
during the following week.
|